Gender differences in brain metabolic and plasma catecholamine responses to alpha2-adrenoceptor blockade

Neuropsychopharmacology

Volumn 16, Issue 4, 1997, Pages 298-310

  Schmidt, Mark E ^a,d   Matochik, John A ^c   Goldstein, David S ^b   Schouten, Jennifer L ^a   Zametkin, Alan J ^a   Potter, William Z ^d  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^d ELI LILLY AND COMPANY   (United States)

Author keywords

18F fluoro deoxyglucose (FDG); Alpha2 adrenoceptor antagonist; Idazoxan; Imidazoline; Positron emission tomography (PET); Sex characteristics

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; CATECHOLAMINE; IDAZOXAN;

ADULT; ANXIETY; ARTICLE; BRAIN METABOLISM; CATECHOLAMINE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; MALE; MOOD; NORMAL HUMAN; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR BLOCKING; SEX DIFFERENCE;

ADRENERGIC ALPHA-ANTAGONISTS; ADULT; BLOOD PRESSURE; BRAIN CHEMISTRY; CATECHOLAMINES; DEOXYGLUCOSE; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; GLUCOSE; HEART RATE; HUMANS; IDAZOXAN; MALE; RECEPTORS, ADRENERGIC, ALPHA-2; SEX CHARACTERISTICS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0030987208     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(96)00264-3     Document Type: Article

References (67)

1. 2A-adrenergic receptor-like immunoreactivity. Brain Res 650:181-204
2. Bartlett EJ, Brodie JD, Wolf AP, Christman DR, Laska E, Meissner M (1988): Reproducibility of cerebral glucose metabolic measurements in resting human subjects. J Cereb Blood Flow Metab 8:502-512
3. Baumbach GL, Heistad DD (1985): Regional, segmental, and temporal heterogeneity of cerebral vascular autoregulation. Ann Biomed Eng 13:303-310
4. 3H]-atipamezole. Eur J Pharmacol 224:27-38
5. Bouvier C, Lagacé G, Collu R (1991): G protein modulation by estrogens. Mol Cell Endocrinol 79:65-73
6. Brooks RA, Di Chiro G, Zukerberg BW, Bairamian D, Larson SM (1987): Test-retest studies of cerebral glucose metabolism using fluorine-18 deoxyglucose: Validation of method. J Nucl Med 28:53-59
7. Chang JY, Duara R, Barker W, Apicella A, Finn R (1987): Two behavioral states studied in a single PET/FDG procedure: Theory, method, and preliminary results. J Nucl Med 28:852-860
8. Chang JY, Duara R, Barker W, Apicella A, Yoshi F, Kelley RF, Ginsberg MD, Boothe TE (1989): Two behavioral states studied in a single PET/FDG procedure: Error analysis. J Nucl Med 30:93-105
9. Charney DS, Heninger GR, Breier A (1984): Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder. Arch Gen Psychiatr 41:751-763
10. Clark C, Carson R, Kessler R, et al. (1985): Alternative statistical models for the examination of clinical positron emission tomography/fluorodeoxyglucose data. J Cereb Blood Flow Metab 5:142-150
11. Davidson L, Vandongen R, Rouse IL, Beilin LJ, Tunney A (1984): Sex-related differences in resting and stimulated plasma noradrenaline and adrenaline. Clin Sci 67:347-352
12. Delamarche P, Gratas-Delamarche A, Monnier M, Mayet MH, Koubi HE, Favier R (1994): Glucoregulation and hormonal changes during prolonged exercise in boys and girls. Eur J Appl Physiol 68:3-8
13. Del Rio G, Verlardo A, Zizzo G, Marrama P, Della Casa L (1993): Sex differences in catecholamine response to clonidine. Int J Obes Metab Disord 17:465-469
14. 3H]-rauwolscine. Brain Res 566:13-20
15. 2B-adrenoceptor subtypes in post mortem human brain. J Neurochem 58:1555-1560
16. 2-adrenoceptors play a major role in the effects of idazoxan on cortical noradrenaline release (as measured by in vivo dialysis) in the rat. J Pharmacol Exp Ther 241:642-649
17. Diamond MP, Jones T, Caprio S, Hallarman L, Diamond MC, Addabbo M, Tamborlane WV, Sherwin RS (1993): Gender influences counterregulatory hormone responses to hypoglycemia. Metabolism 42:1568-1572
18. 2-adrenoceptors. Br J Pharmacol 78:489-505
19. Du XJ, Dart AM, Riemersa RA, Oliver MF (1991): Sex difference in presynaptic adrenergic inhibition of norepinephrine release during normoxia and ischemia in the rat heart. Circ Res 68:827-835
20. Eaton WW, Kessler RC, Wittchen HU, Magee WJ (1994): Panic and panic disorder in the United States. Am J Psychiatry 151:413-420
21. Eisenhofer G, Goldstein DS, Stull R, Keiser HR, Sunderland T, Murphy T, Murphy DL, Kopin IJ (1986): Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clin Chem 32:2030-2033
22. Eisenhofer G, Friberg P, Pacak K, Goldstein DS, Murphy DL, Tsigos C, Quyyumi AA, Brunner HG, Lenders JWM (1995): Plasma metadrenalines: Do they provide useful information about sympatho-adrenal function and catecholamine metabolism? Clin Sci 88:533-542
23. Elliott HL, Jones CR, Vincent J, Lawrie CB, Reid JL (1984): The alpha adrenoceptor antagonist properties of idazoxan in normal subjects. Clin Pharmacol Ther 36:190-196
24. 3H]-labeled monoamines by hypothalamic tissue in vitro. Brain Res 73:321-331
25. Frankenhauser M, Dunne E, Lundberg U (1976): Sex differences in sympathetic-adrenal medullary reactions induced by different stressors. Psychopharmacology 47:1-5
26. 2-adrenoceptors on rat central neurons. Eur J Pharmacol 105:265-272
27. Freedman RR, Sabharwal SC, Desai N (1987) Sex differences in peripheral vascular adrenergic receptors. Circ Res 61:581-585
28. 14C]2-deoxyglucose and microdialysis studies. Neuropharmacology 34:605-613
29. Friston KJ, Frith CD, Liddle PF, Frackowlak RSJ (1991): Comparing functional (PET) images: The assessment of significant change. J Cer Blood Flow Metab 11:690-699
30. Gerber JC, Choki J, Brunswick DJ, Reivich M, Frazer A (1983): The effect of antidepressant drugs on regional cerebral glucose utilization in the rat. Brain Res 269: 319-325
31. Goldstein DS, Grossman E, Listwak S, Folio CJ (1991): Sympathetic reactivity during a yohimbine challenge test in essential hypertension. Hypertension 18 (5 suppl):III 40-48
32. Grossman E, Rea RF, Hoffman A, Goldstein DS (1991): Yohimbine increases sympathetic nerve activity and norepinephrine spillover in normal volunteers. Am J Physiol 260:R142-147
33. 2-adrenoceptors in rat brain after short-term DSP-4 lesioning. Eur J Pharmacol 249:37-41
34. 2-adrenergic receptor binding in human platelets; Alterations during the menstrual cycle. Clin Pharmacol Ther 34:90-96
35. 2-adrenoceptor-mediated inhibition of hypothalamic norepinephrine release. J Neurosci 13:3448-3455
36. 2D subtype. Mol Pharmacol 45:509-516
37. Kiefel JM, Bodnar RJ (1991): Roles of gender and gonadectomy in pilocarpine and clonidine analgesia in rats. Pharmacol Biochem Behav 41:153-158
38. Luine VN, McEwen BS (1977): Effect of estradiol on turnover of type A monoamine in brain. J Neurochem 28:1221-1227
39. Manji HK (1992): G proteins: Implications for psychiatry. Am J Psychiatr 149:746-760
40. 2-adrenoceptors. Neurosci Lett 86:328-333
41. 15)O positron emission tomography in humans. J Cereb Blood Flow Metab 13:748-754
42. 2-adrenergic receptors. Mol Pharmacol 35:324-330
43. Minoshima S, Berger KL, Lee KS, Mintun MA (1992): An automated method for rotational correction and centering of three-dimensional functional/brain images. J Nucl Med 33:1579-1585
44. Nyback HV, Walters JR, Aghajanian GK (1975): Tricyclic antidepressants: Effects on the firing rate of brain noradrenergic neurons. Eur J Pharmacol 32:302-312
45. Parada S, Galleguillos X, Forray MI, Belmar J (1991): Changes of norepinephrine levels and release in rat cerebral cortex during the estrous cycle. NeuroReport 2:801-804
46. 2-adrenoceptors in the human brain. Brain Res 585:116-127
47. 3H]-p-aminoclonidine. Eur J Pharmacol 106:477-488
48. 2-adrenoceptors in the human cerebral cortex. Naunyn-Schmiedebergs Arch Pharmacol 342:508-512
49. 2-adrenoceptor binding sites on intact platelets of young male volunteers. Eur J Clin Pharmacol 33:147-150
50. Sachs H, Wolf A, Russell JAG, Christman D (1986): Effect of reserpine on regional cerebral glucose metabolism in control and migraine subjects. Arch Neurol 43:1117-1123
51. Sanchez J, Pequignot JM, Peyrin L, Monod H (1980): Sex differences in the sympatho-adrenal response to isometric exercise. Eur J Appl Physiol 45:147-154
52. 2 with monoamine oxidase-B sites. J Neurochem 61:881-889
53. Savaki HE, Kadekaro M, McCullouch J, Sokoloff L (1982): The central noradrenergic system in the rat: Metabolic mapping with alpha-adrenergic blocking agents. Brain Res 234:65-79
54. Scatton B, Zivkovic B, Dedek J (1980): Antidopaminergic properties of yohimbine. J Pharmacol Exp Ther 215:494-499
55. 2 blockade by idazoxan. Clin Pharmacol Ther 57:684-695
56. Schmidt ME, Ernst M, Matochik JA, Maisog JM, Pan BS, Zametkin AJ, Potter WZ (1996): Cerebral glucose metabolism during pharmacologic studies: Test-retest under placebo conditions. J Nucl Med 37:1142-1149
57. 2-adrenoceptor blockade by idazoxan in healthy male and female volunteers. Psychoneuroendocrinology
58. Siever LJ, Davis KL (1985): Overview: Toward a dysregulation hypothesis of depression. Am J Psychiatr 142:1017-1031
59. Spielberger CD, Gorsuch RL, Lushene RE (1983): Manual for the State-Trait Anxiety Inventory (Form Y). Palo Alto, CA: Consulting Psychologists Press
60. 2-adrenoceptors and the menstrual cycle. Clin Pharmacol Ther 37:337-342
61. Talairach J, Tournoux P (1988): Co-Planar Stereotaxic Atlas of the Human Brain: Three-Dimensional Proportional System, An Approach to Cerebral Imaging. New York, Thieme
62. Tulandi T, Lal S, Guyda H (1987): Effect of estrogen on the growth hormone response to the α-adrenergic agonist clonidine in women with menopausal flushing. J Clin Endocrinol Metab 65:6-10
63. van Veldhuizen MJA, Feenstra MGP, Heinsbroek RPW, Boer GJ (1993): In vivo microdialysis of noradrenaline overflow: Effects of α-adrenoceptor agonists and antagonists measured by cumulative concentration-response curves. Br J Pharmacol 109:655-660
64. Vizi ES (1980): Modulation of cortical release of acetylcholine by noradrenaline released from nerves arising from the rat locus coeruleus. Neuroscience 5:2139-2144
65. Weissman MM, Klerman GL (1977): Sex differences and the epidemiology of depression. Arch Gen Psychiatr 34: 98-111
66. Williams PD, Puddey IB, Beilin LJ, Vandogen R (1993): Genetic influences on plasma catecholamines in human twins. J Clin Endocrin Metab 77:794-799
67. Winter JC, Rabin RA (1992): Yohimbine as a serotonergic agent: Evidence from receptor binding and drug discrimination, J Pharmacol Exp Ther 263:682-689